The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double-blind controlled randomized trial

Omid Toupchian, Shima Abdollahi, Amin Salehi-Abargouei, Javad Heshmati, Cain C.T. Clark, Mohammad Hasan Sheikhha, Hossein Fallahzadeh, Hassan Mozaffari-Khosravi*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    9 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)3205-3213
    Number of pages9
    JournalPhytotherapy Research
    Volume35
    Issue number6
    DOIs
    Publication statusPublished (VoR) - Jun 2021

    Funding

    Iran's National Science Foundation, Grant/Award Number: 96010660; Shahid Sadoughi University of Medical Sciences, Grant/Award Number: 4694 Funding information The authors express their gratitude to all participants as well as Yazd Diabetes Research Center for their enthusiastic collaboration. This work was supported by grants from Shahid Sadoughi University of Medical Sciences (grant no: 4694) and Iran's National Science Foundation (INSF) (grant no: 96010660), which are thanked for their financial and executive support.

    FundersFunder number
    Iran National Science Foundation96010660
    Shahid Sadoughi University of Medical Sciences4694

      Keywords

      • cardiovascular diseases
      • resveratrol
      • sCD163
      • sTWEAK
      • type 2 diabetes mellitus

      Fingerprint

      Dive into the research topics of 'The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double-blind controlled randomized trial'. Together they form a unique fingerprint.

      Cite this